ArticleHuman vaccines & immunotherapeutics2023

The immunogenicity and the safety of the adjuvanted glycoprotein E (gE)-based recombinant vaccine against herpes zoster (RZV) in cancer patients during immunotherapy.

Angioletta Lasagna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.